Long-term outcome of LRBA deficiency in 76 patients after various treatment modalities as evaluated by the immune deficiency and dysregulation activity (IDDA) score

2019155 citationsJournal Articlehybrid Open Access

Authors

The lifelong disease activity, implying a need for immunosuppression and risk of malignancy, must be weighed against the risks of HSCT.

Good health and well-being

Published in: Journal of Allergy and Clinical Immunology

Volume 145, Issue 5, pp. 1452-1463

Field-Weighted Citation Impact: 7.35